Ascribe Bio Raises $12M Series A Led by Corteva Catalyst and Acre Venture Partners

Deal Summary

Ascribe Bio closed a $12M Series A round co-led by Corteva (via Corteva Catalyst) and Acre Venture Partners, with participation from Syngenta Group Ventures, Trailhead Capital, Silver Blue LLC, Cultivation Capital, and The Yield Lab. The Ithaca-based natural crop protection company will use the funds to advance its products and growth.